CASE STUDY

Screening activity reactivated – Camovis helps overcome CAR-T documentation backlogs
  • Locations: 1 site

  • Flying Research Professionals deployed: 1
  • Focus area: Data handling
  • Achievements: 400 open queries processed

Summary

For a complex Phase I study in the field of CAR-T therapy, Camovis is supporting a study site with a Flying Research Professional.
The assignment began in a challenging situation: a high documentation workload and a significant backlog in the eCRF had temporarily prevented the site from enrolling new patients.

The current focus of the deployment is ongoing data entry in the eCRF as well as organizing of the ISF filing system, with the goal of ensuring accurate and timely documentation of numerous closely scheduled study visits.

When backlogs block study operations

A large number of concurrent patient visits, extended hospitalization during the first treatment cycle, and the significant workload involved in the dose-finding phase led to a substantial documentation backlog. Open queries and incomplete ISF filing prevented the continuous progress of study activities.

 

Step by step toward data control

The targeted involvement of the Flying Research Professional provided significant relief. Through regular on-site support, ongoing eCRF documentation was maintained and open queries were systematically resolved. This made it possible to reduce backlogs, ensure data quality, and enable the resumption of patient recruitment at the study site.

 

🏆 Successful outcomes through targeted support

Thanks to the focused deployment of our Flying Research Professional, a total of 400 open queries were resolved and ongoing data capture was successfully stabilized. Timely documentation was restored, ensuring efficient patient management. During this period, 6 prescreenings and 3 screenings were successfully completed, with additional screenings already planned.

This outcome once again demonstrates how targeted support from our Flying Research Professionals can significantly strengthen study operations — particularly in highly complex indications such as CAR-T therapy, where precision, speed, and compliance are critical.